Company Filing History:
Years Active: 1991
Title: Sanjai Kumar: Innovator in Malaria Vaccine Development
Introduction
Sanjai Kumar is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines against malaria. His innovative work focuses on creating synthetic vaccines that can effectively combat the P. falciparum malaria parasite.
Latest Patents
Sanjai Kumar holds a patent for a synthetic vaccine against P. falciparum malaria. This patent describes a purified peptide that induces proliferation or activation of cytotoxic T cells specifically against the circumsporozoite protein of P. falciparum. The peptide has an amino acid sequence of KPKDELDYENDIEKKICKMEKCS in single-letter amino acid code. This groundbreaking work has the potential to advance malaria treatment and prevention strategies.
Career Highlights
Sanjai Kumar is associated with the United States of America as represented by the Department of Health. His role in this esteemed organization highlights his commitment to public health and innovation in vaccine development. His work is crucial in addressing global health challenges posed by malaria.
Collaborations
Some of his notable coworkers include Michael F. Good and Jay A. Berzofsky. Their collaboration in research and development has contributed to the advancement of vaccine technologies and has fostered a productive environment for innovation.
Conclusion
Sanjai Kumar's contributions to the field of malaria vaccine development exemplify the impact of innovative research on global health. His work not only addresses a critical health issue but also showcases the importance of collaboration in scientific advancements.